Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Second Sight Medical Products Inc    EYES

SECOND SIGHT MEDICAL PRODUCTS INC

(EYES)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

SECOND SIGHT MEDICAL PRODUCTS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/23/2019 | 04:04pm EDT

ITEM 7.01. REGULATION FD DISCLOSURE

A copy of a slide presentation that Second Sight Medical Products, Inc. ("Second Sight") intends to use during a presentation at the B. Riley FBR Investor Conference in Beverly Hills, CA on May 23, 2019 (the "Presentation Materials") is attached to this Current Report on Form 8-K as Exhibit 99.1, and is incorporated by reference herein. The Presentation Materials speak as of the date of this Current Report on Form 8-K. While Second Sight may elect to update the Presentation Materials in the future or reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K, Second Sight specifically disclaims any obligation to do so. Additionally, the B. Riley FBR Investor Conference presentation will be webcast at 3:30 P.M. Pacific Daylight Time on May 23, 2019 at http://www.wsw.com/webcast/brileyfbr3/eyes. The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company's website at www.secondsight.com, under the Investors section. The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by reference in such a filing.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS



 Exhibit No. Description


99.1 Second Sight Medical Products, Inc. Investor Presentation dated May 23, 2019.

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SECOND SIGHT MEDICAL PRODU
08/06SECOND SIGHT MEDICAL PRODUCTS : 2Q Earnings Snapshot
AQ
08/06SECOND SIGHT MEDICAL PRODUCTS : Management's Discussion and Analysis of Financia..
AQ
08/06SECOND SIGHT MEDICAL PRODUCTS INC : Results of Operations and Financial Conditio..
AQ
08/06SECOND SIGHT MEDICAL PRODUCTS :  Second Sight Reports Second Quarter 2019 Financ..
BU
07/30SECOND SIGHT MEDICAL PRODUCTS : to Discuss Second Quarter 2019 Financial Results..
BU
07/26SECOND SIGHT MEDICAL PRODUCTS INC : Notice of Delisting or Failure to Satisfy a ..
AQ
06/25SECOND SIGHT MEDICAL PRODUCTS : Researchers Present Latest Positive Results of S..
BU
06/25SECOND SIGHT MEDICAL PRODUCTS INC : Regulation FD Disclosure, Other Events, Fina..
AQ
06/05SECOND SIGHT MEDICAL PRODUCTS INC : Submission of Matters to a Vote of Security ..
AQ
05/23SECOND SIGHT MEDICAL PRODUCTS INC : Regulation FD Disclosure, Financial Statemen..
AQ
More news
Financials (USD)
Sales 2019 4,17 M
EBIT 2019 -33,9 M
Net income 2019 -33,8 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -2,79x
P/E ratio 2020 -3,12x
Capi. / Sales2019 24,2x
Capi. / Sales2020 106x
Capitalization 101 M
Chart SECOND SIGHT MEDICAL PRODUCTS INC
Duration : Period :
Second Sight Medical Products Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SECOND SIGHT MEDICAL PRODU
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 2,50  $
Last Close Price 0,81  $
Spread / Highest target 209%
Spread / Average Target 209%
Spread / Lowest Target 209%
EPS Revisions
Managers
NameTitle
Jonathan Will McGuire President, Chief Executive Officer & Director
Gregg G. Williams Chairman
William Patrick Ryan Chief Operating Officer
John T. Blake Chief Financial Officer & Secretary
Edward Randolph VP-Operations, Quality & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
SECOND SIGHT MEDICAL PRODUCTS INC-8.53%97
STRYKER CORPORATION38.44%80 330
SMITH & NEPHEW29.61%19 879
GLAUKOS CORP12.05%2 236
INSPIRE MEDICAL SYSTEMS INC54.98%1 558
JAPAN LIFELINE CO., LTD.28.74%1 307